Analysis of unnecessary GI medicine use
Among 1,546 patients who were taking unnecessary GI drugs,
three-quarters (74.15%) were prescribed antiulcer drugs, and a quarter
(25.85%) were prescribed GI tract regulators. As shown in Fig. 2, the
antiulcer drugs most used were mucosal protectives (i.e., rebamipide,
56.21%), followed by H2-receptor blockers (20.71%), antacids
(18.18%), and PPIs (4.90%). Among GI tract regulators, GI tract
stimulants such as mosapride accounted for 85.71%, followed by
anticholinergics (13.38%), and others (0.91%).